21 hours ago · Mitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678, and focusing on ethical pharmaceuticals. MTPC is headquartered in Doshomachi, Osaka, the birthplace of Japan’s pharmaceutical industry. ...

10 hours ago · Mitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678, and focusing on ethical ...

Jan 29, 2025 · See the latest status of our innovative investigational therapies and pipeline as well as read stories, explore our company, and connect with us.

Dec 5, 2024 · Mitsubishi Tanabe Pharma America, Inc. Mitsubishi Tanabe Pharma Canada, Inc. MP Healthcare Venture Management, Inc. Mitsubishi Tanabe Pharma Europe Ltd. Mitsubishi Tanabe Pharma GmbH; NeuroDerm Ltd. Taiwan Tanabe Seiyaku Co., Ltd. Mitsubishi Tanabe Pharma Korea Co., Ltd. PT Mitsubishi Tanabe Pharma Indonesia

10 hours ago · The deal values Mitsubishi Tanabe Pharma Corp. at about ¥510 billion ($3.3 billion), according to a statement on Friday, which confirmed an earlier report from Bloomberg News. The transaction is ...

14 hours ago · Bain buys 340-year-old pharma company to fast-track Japan’s drug development Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine

10 hours ago · Core operating profit from its pharma business declined 1.6% to Y54.5 billion for the nine months ended December, while revenue rose 3.3% to Y349.1 billion, Mitsubishi Chemical said Thursday.

The Japanese chemical company said Friday that it would sell unit Mitsubishi Tanabe Pharma to the U.S. investment company for about 510 billion yen, equivalent to $3.37 billion.

Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceuticals company from Osaka, [1] a subsidiary of Mitsubishi Chemical Holdings Corporation. Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社, Mitsubishi Werufāma Kabushiki-gaisha) was formed in 2001 from the merger of Mitsubishi-Tokyo Pharmaceuticals and Welfide ...

For more than 300 years, our parent company, Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, has proudly pursued medical advances; we’ve discovered and produced several first in class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM) and amyotrophic lateral sclerosis (ALS).